11.01.2010 17:10:00

New York Downtown Hospital Advances Use of Technology with Eclipsys’ Clinical Solutions

Eclipsys Corporation® (NASDAQ: ECLP), The Outcomes Company®, today announced that New York Downtown Hospital (New York Downtown) will launch a major information technology (IT) initiative involving multiple integrated components of the company’s Sunrise Enterprise™ suite of solutions. The new applications will advance New York Downtown’s use of enabling applications by creating a single electronic health record (EHR) across venues to improve the quality, safety and continuity of care. The initiative also sets the stage for the Lower Manhattan hospital to meet the expected "meaningful use” requirements of the American Recovery and Reinvestment Act (ARRA) of 2009.

Expanded Use of Technology for a Single EHR from Emergency Room to Bedside

New technology solutions include Sunrise Acute Care™, Eclipsys’ industry-leading computerized physician order entry (CPOE) system, Sunrise Pharmacy™, its integrated pharmacy information system, along with the company’s emergency care solution, Sunrise Emergency Care™. In combination, these applications will create a single and unified view of up-to-date patient information from the emergency room to bedside and into the hospital pharmacy.

The CPOE solution will provide physicians with clinical decision support resources at the point of care in the form of order sets and evidence-based treatment guidelines. Moreover, the tight integration between Eclipsys’ CPOE and pharmacy solutions sets the stage to help New York Downtown in meeting what is expected to be the medication management component of ARRA. Expected clinical benefits include eliminating the need to manually transcribe medication orders, improved care coordination between pharmacists and clinicians, enhanced medication delivery time and improved accuracy of carrying out physician orders—all which support improved patient outcomes.

"Living in close proximity to the diverse residential and business communities of Lower Manhattan, our patients insist on the highest levels of technological sophistication in their healthcare services,” said Warren B. Licht, M.D., New York Downtown Hospital’s Chief Medical Officer. "Our No. 1 strategy goal in this endeavor is to create an integrated technology environment that will support improved quality and effectiveness. In fact, we were reviewing technology options prior to the passage of ARRA, but the promise of economic benefit has been an impetus for us to move forward quickly. We selected Eclipsys because we have enjoyed a positive working relationship, and as a company, it goes unmatched in helping clients achieve deep adoption of technology. We expect Eclipsys to fully support us in satisfying what we expect to be the meaningful use requirements of ARRA.”

Industry Leadership in Physician Adoption

With a national spotlight on adoption of EHRs to improve the quality and cost-containment of the U.S. healthcare system, New York Downtown has chosen to partner with the company that leads the healthcare information technology industry in physician adoption of and satisfaction with CPOE technology. Eclipsys leads the industry in total physicians live on CPOE, as well as the percentage of its client base using the system, according to the KLAS CPOE Digest 2009: Meaningful Use and Physician Adoption report. In addition, Eclipsys’ acute care EHR is ranked No. 2 in its category in the 2009 "Top 20 Best in KLAS Award: Software and Professional Services” report. Eclipsys’ pharmacy solution is ranked No. 4 in the industry according to the same report.

"We are pleased New York Downtown Hospital has placed their confidence in our proven track record of successfully supporting deep client adoption of clinical software, which is critical to meeting the expected meaningful use requirements of ARRA,” said Jay Deady, Eclipsys’ executive vice president of Client Solutions. "In addition to know-how in supporting adoption, we offer clients a fully integrated clinical system, embedded complex algorithms that transcend fundamental order entry, and proven methodologies to support organizations in realizing clinical performance goals. We look forward to working with New York Downtown as they pursue their dual goals of creating an integrated care environment and qualification for federal stimulus dollars.”

With more than 30 years of experience, Eclipsys has leveraged the input of thousands of physicians for evidence-based order sets and frequently used protocols to achieve unmatched, continuous evolution in its CPOE capabilities. The intuitive, easy-to-adopt solution offers highly complex clinical decision support capabilities that provide workflows tailored to how physicians practice medicine and support automating even the most complex order sets and medication ordering, including the exacting protocols, long-range medication schedules and complicated treatment plans commonplace in oncology and pediatric care environments.

New York Downtown also has opted to deploy Eclipsys’ Sunrise Record Manager™ solution to free up valuable storage space, facilitate comprehensive chart tracking and requests, chart completion, release of information, electronic signature and medical record abstracting. In addition, the hospital has renewed its services agreement with Eclipsys to support it in major aspects of the IT project and ongoing system maintenance.

About New York Downtown Hospital

New York Downtown Hospital (NYDH) delivers state-of-the-art healthcare with the intimate attention and compassion of a community hospital. As the closest acute care hospital to the 600,000 people who work and live in Lower Manhattan, NYDH’s mission is to serve the people who comprise the diverse business and residential communities of Wall Street, Chinatown, SoHo, TriBeCa, Battery Park City and the Lower East Side. Each year, the Hospital has more than 37,000 emergency visits, 146,000 outpatient visits, 11,000 inpatients, 5,300 outpatient surgeries and 2,400 new babies born. For more information, see http://www.downtownhospital.org/.

About KLAS

KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to www.KLASresearch.com, or email marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a KLAS representative.

About the KLAS CPOE Digest 2009

The KLAS CPOE Digest 2009 compiled data from healthcare executives, managers and clinicians. The study provided detailed information on several criteria including current CPOE usage at healthcare organizations, product capabilities and vendor performance.

About the 2009 Top 20 Best in KLAS Awards: Software and Professional Services report

The report reflects the summary of healthcare information technology (HIT) software and professional services performance data as reported by physician offices, clinics, IDNs, inpatient facilities, and applicable healthcare agencies. The HIT software ratings reflect data collected over the past 12 months (October 15, 2008 – November 15, 2009); the professional services ratings reflect data collected over the past 18 months (May 15, 2008 – November 15, 2009). Each product or segment is listed by market segment.

About What is Meaningful

The HITECH portion of The American Recovery and Reinvestment Act has set the HIT industry on a quest for answers to many questions. Eclipsys is sponsoring a new web site to solicit opinions on these questions. The site, www.whatismeaningful.com, was created to promote, educate and provide a valuable resource that informs and delivers best practices. This web site will go beyond the government definitions of meaningful use and explore how providers can drive improved outcomes through the use of healthcare information technology. Visit this web site to keep informed of the latest information being shared about ARRA.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle, and performance management software and services that help healthcare organizations improve clinical, financial, operational and client-satisfaction outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.

Statements in this news release concerning the timing of implementation and features and benefits provided by Eclipsys software, ARRA qualification, evidence-based content and implementation and remote hosting services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and client-specific configuration of Eclipsys software can be complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from software, content or services. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances, ARRA qualification requires compliance with standards that are still evolving, and satisfaction of those standards may be delayed. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors” and "Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise Enterprise, Sunrise Acute Care, Sunrise Emergency, Sunrise Pharmacy and Sunrise Record Manager are trademarks of Eclipsys Corporation. Other product and company names in this news release are or may be trademarks and/or registered trademarks of their respective companies.

Nachrichten zu Allscripts Healthcare Solutions Incmehr Nachrichten

26.09.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel hätte eine Investition in Allscripts Healthcare Solutions von vor einem Jahr gekostet (finanzen.at)
19.09.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel Verlust wäre bei einem Investment in Allscripts Healthcare Solutions von vor 10 Jahren angefallen (finanzen.at)
12.09.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger mit einem Investment in Allscripts Healthcare Solutions von vor 5 Jahren verloren (finanzen.at)
05.09.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger an einem Allscripts Healthcare Solutions-Investment von vor 3 Jahren verloren (finanzen.at)
29.08.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel Verlust hätte eine Allscripts Healthcare Solutions-Investition von vor einem Jahr eingebracht (finanzen.at)
22.08.24
NASDAQ Composite Index-Wert Allscripts Healthcare Solutions-Aktie: So viel hätte eine Investition in Allscripts Healthcare Solutions von vor 10 Jahren gekostet (finanzen.at)
15.08.24
NASDAQ Composite Index-Wert Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger an einem Allscripts Healthcare Solutions-Investment von vor 5 Jahren verdient (finanzen.at)
08.08.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel Verlust hätte ein Investment in Allscripts Healthcare Solutions von vor 3 Jahren eingebracht (finanzen.at)

Analysen zu Allscripts Healthcare Solutions Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Allscripts Healthcare Solutions Inc 9,20 4,55% Allscripts Healthcare Solutions Inc